Webex Link: https://uwhealth.webex.com/uwhealth/j.php?MTID=m398b5099541b81f1b40740bd5e213c1f

Learning Objectives:

  • Define Smoldering Multiple Myeloma (SMM) and differentiate SMM from Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS)

  • Analyze SMM risk stratification and apply risk of progression to treatment decision scenarios

  • Compare controversies in early intervention vs observation management approaches

Session date: 
04/10/2025 - 2:00pm to 3:00pm CDT
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
See map: Google Maps
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Savannah Anderson, PharmD